Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

5P12-RANTES

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Antiretroviral‐releasing vaginal rings are at the forefront of ongoing efforts to develop microbicide‐based strategies… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Review
2019
Review
2019
The past fifteen years have witnessed a resurgence of interest in vaginal ring technologies for drug delivery applications… Expand
  • table 2
  • table 1
2017
2017
ABSTRACT 5P12-RANTES, a chemokine analogue that potently blocks the HIV CCR5 coreceptor, is being developed as both a vaginal and… Expand
2017
2017
In the absence of an effective vaccine, strategies to prevent HIV transmission are urgently needed. Condomless receptive anal… Expand
  • table 1
  • figure 2
  • figure 4
  • figure 5
2017
2017
Despite effective treatment for those living with Human Immunodeficiency Virus (HIV), there are still two million new infections… Expand
2017
2017
Viral resistance to small molecule allosteric inhibitors of CCR5 is well documented, and involves either selection of preexisting… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 4
  • table 2
2013
2013
5P12-RANTES is a recently developed chemokine analogue that has shown high level protection from SHIV infection in macaques… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
RANTES (CCL5) is a chemokine that recruits immune cells to inflammatory sites by interacting with the G-protein coupled receptor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Viral resistance to small molecule allosteric inhibitors of CCR5 is well documented, and involves either selection of preexisting… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 4
  • table 2
Highly Cited
2008
Highly Cited
2008
New prevention strategies for use in developing countries are urgently needed to curb the worldwide HIV/AIDS epidemic. The N… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3